Quest Diagnostics (DGX) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $432.0 million.
- Quest Diagnostics' Cash & Current Investments fell 4345.55% to $432.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $432.0 million, marking a year-over-year decrease of 4345.55%. This contributed to the annual value of $549.0 million for FY2024, which is 1997.08% down from last year.
- As of Q3 2025, Quest Diagnostics' Cash & Current Investments stood at $432.0 million, which was down 4345.55% from $319.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Cash & Current Investments ranged from a high of $1.2 billion in Q1 2021 and a low of $126.0 million during Q2 2023
- For the 5-year period, Quest Diagnostics' Cash & Current Investments averaged around $541.7 million, with its median value being $549.0 million (2024).
- Per our database at Business Quant, Quest Diagnostics' Cash & Current Investments plummeted by 8405.06% in 2023 and then skyrocketed by 43426.57% in 2024.
- Quest Diagnostics' Cash & Current Investments (Quarter) stood at $872.0 million in 2021, then crashed by 63.88% to $315.0 million in 2022, then skyrocketed by 117.78% to $686.0 million in 2023, then dropped by 19.97% to $549.0 million in 2024, then decreased by 21.31% to $432.0 million in 2025.
- Its Cash & Current Investments was $432.0 million in Q3 2025, compared to $319.0 million in Q2 2025 and $188.0 million in Q1 2025.